407 related articles for article (PubMed ID: 34205140)
1. The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment.
Tempest R; Guarnerio S; Maani R; Cooper J; Peake N
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34205140
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase-2 Mediates the Biomechanical Properties of the Colorectal Cancer Tissue Microenvironment that Contribute to Disease Progression.
Delaine-Smith R; Wright N; Hanley C; Hanwell R; Bhome R; Bullock M; Drifka C; Eliceiri K; Thomas G; Knight M; Mirnezami A; Peake N
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31117256
[TBL] [Abstract][Full Text] [Related]
3. The Role of Transglutaminase 2 in Cancer: An Update.
Zaltron E; Vianello F; Ruzza A; Palazzo A; Brillo V; Celotti I; Scavezzon M; Rossin F; Leanza L; Severin F
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474044
[TBL] [Abstract][Full Text] [Related]
4. The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.
Tabolacci C; De Martino A; Mischiati C; Feriotto G; Beninati S
Med Sci (Basel); 2019 Jan; 7(2):. PubMed ID: 30691081
[TBL] [Abstract][Full Text] [Related]
5. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
Bagatur Y; Ilter Akulke AZ; Bihorac A; Erdem M; Telci D
Cell Adh Migr; 2018 Mar; 12(2):138-151. PubMed ID: 28498731
[TBL] [Abstract][Full Text] [Related]
7. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2 in cancer.
Huang L; Xu AM; Liu W
Am J Cancer Res; 2015; 5(9):2756-76. PubMed ID: 26609482
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
Ayinde O; Wang Z; Griffin M
Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma.
Nezir AE; Ulukan B; Telci D
Med Sci (Basel); 2019 Feb; 7(2):. PubMed ID: 30736384
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the development of tissue transglutaminase (TG2) inhibitors.
Badarau E; Collighan RJ; Griffin M
Amino Acids; 2013 Jan; 44(1):119-27. PubMed ID: 22160259
[TBL] [Abstract][Full Text] [Related]
13. Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2.
Biri B; Kiss B; Király R; Schlosser G; Láng O; Kőhidai L; Fésüs L; Nyitray L
Biochem J; 2016 Jan; 473(1):31-42. PubMed ID: 26487698
[TBL] [Abstract][Full Text] [Related]
14. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase in tumour progression: friend or foe?
Kotsakis P; Griffin M
Amino Acids; 2007 Aug; 33(2):373-84. PubMed ID: 17581697
[TBL] [Abstract][Full Text] [Related]
16. Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
Ulukan B; Bihorac A; Sipahioglu T; Kiraly R; Fesus L; Telci D
ACS Omega; 2020 Nov; 5(43):28273-28284. PubMed ID: 33163811
[TBL] [Abstract][Full Text] [Related]
17. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase promotes or suppresses tumors depending on cell context.
Chhabra A; Verma A; Mehta K
Anticancer Res; 2009 Jun; 29(6):1909-19. PubMed ID: 19528447
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
20. The Role of Glypican-1 in the Tumour Microenvironment.
Lund ME; Campbell DH; Walsh BJ
Adv Exp Med Biol; 2020; 1245():163-176. PubMed ID: 32266658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
